CompletedNot Applicable

Effect of Primary Care Education on Parents' Health-Related Perceptions and Attitudes

Turkey (Türkiye)173 participantsStarted 2026-01-20

Plain-language summary

This study aims to evaluate the effect of a structured education program delivered in primary health care settings on parents of children aged 0-2 years. The education focuses on childhood vaccination and related health perceptions. Parents will receive education covering childhood vaccines, vaccine hesitancy, evaluation of vaccine-related information obtained from digital sources, eco-anxiety, and perceived vulnerability to diseases. The study examines whether this education influences parents' levels of vaccine hesitancy, digital vaccine literacy, eco-anxiety, and perceived vulnerability to diseases. The findings are expected to contribute to the development of effective educational interventions in primary health care services to support informed parental decision-making regarding childhood vaccination.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Parents who have at least one child aged 0-2 years * Attendance at the Van Tuşba Family Health Center * Ability to read and write in Turkish * Willingness to participate voluntarily in the study * Provision of written informed consent Exclusion Criteria: * Individuals with a diagnosed psychiatric disorder * Individuals with cognitive or sensory impairments that prevent effective communication * Individuals who are unable to attend the education sessions * Individuals who do not complete the baseline assessment

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Vaccine Hesitancy Level

Timeframe: Baseline (pre-intervention) and 15 days after completion of the education program

Digital Vaccine Literacy Level

Timeframe: Baseline and 15 days after completion of the education program

Eco-Anxiety Level

Timeframe: Baseline and 15 days after completion of the education program

Perceived Vulnerability to Disease

Timeframe: Baseline and 15 days after completion of the education program

Trial details

NCT IDNCT07381088

SponsorYuzuncu Yil University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-20

View on ClinicalTrials.gov More Vaccine Hesitancy trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Vaccine Hesitancy Level

Timeframe: Baseline (pre-intervention) and 15 days after completion of the education program

Digital Vaccine Literacy Level

Timeframe: Baseline and 15 days after completion of the education program

Eco-Anxiety Level

Timeframe: Baseline and 15 days after completion of the education program

Perceived Vulnerability to Disease

Timeframe: Baseline and 15 days after completion of the education program